Association between Helicobacter pylori infection and non-alcoholic fatty liver disease in North Chinese: a cross-sectional study

被引:0
作者
Tian Jiang
Xia Chen
Chenmei Xia
Huamin Liu
Haifan Yan
Guoping Wang
Zhongbiao Wu
机构
[1] The Affiliated Wenling Hospital of Wenzhou Medical University,Research Center for Translational Medicine
[2] Wenling,Department of Urology
[3] The Affiliated Wenling Hospital of Wenzhou Medical University,Department of Gastroenterology
[4] Wenling,School of Public Health
[5] The Affiliated Wenling Hospital of Wenzhou Medical University,undefined
[6] Wenling,undefined
[7] Taishan Medical University,undefined
来源
Scientific Reports | / 9卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) is a common liver disease. Previous studies on the association between Helicobacter pylori (HP) infection and NAFLD are inconsistent. Our study was aimed to find out the relationship between HP infection and NAFLD. We performed a large cross-sectional study in northern Chinese adults in 2015. 13C-urea breath tests were used to determine HP infection status. Abdominal ultrasonography was performed to diagnose NAFLD. Multivariable logistic regression was conducted to identify the association between HP infection and NAFLD. A total of 4081 individuals were included in this study; 2137 (52.36%) participants were HP-positive, and 1022 (47.82%) were diagnosed with NAFLD in HP-positive individuals. The odds ratios (OR) and 95% confidence intervals (CI) of participants with HP infection for NAFLD were 1.20 (1.06–1.36) in crude model and 1.27 (1.07–1.50) in fully adjusted model. When stratified by sex and dyslipidemia, the fully adjusted OR and 95% CI for NAFLD were 1.22 (1.10–1.80) in females and 1.44 (1.18–1.75) in subjects with dyslipidemia. There were not significant increased OR for NAFLD when stratified by age. The study indicate that HP infection is associated with NAFLD, particularly in females and patients with dyslipidemia, suggesting that HP eradication might be an alternative method for the prevention or treatment of NAFLD treatment.
引用
收藏
相关论文
共 43 条
[1]  
Mikolasevic I(2016)Nonalcoholic fatty liver disease - A multisystem disease? World J Gastroenterol. 22 9488-505
[2]  
Yang MH(2016)The associations between apolipoprotein B, A1, and the B/A1 ratio and nonalcoholic fatty liver disease in both normal-weight and overweight Korean population J Clin Lipidol. 10 289-98
[3]  
Sung J(2015)Nonalcoholic fatty liver disease: a systematic review JAMA. 313 2263-73
[4]  
Gwak GY(2010)Epidemiology of non-alcoholic fatty liver disease Dig Dis. 28 155-61
[5]  
Rinella ME(2012)Prevalence of non-alcoholic fatty liver disease and advanced fibrosis in Hong Kong Chinese: a population study using proton-magnetic resonance spectroscopy and transient elastography Gut. 61 409-15
[6]  
Bellentani S(2006)Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses Clin Microbiol Rev. 19 597-613
[7]  
Scaglioni F(2014)Helicobacter pylori infection, insulin resistance and nonalcoholic fatty liver disease Med Hypotheses. 82 795-96
[8]  
Marino M(2018)The impact of Helicobacter pylori infection, eradication therapy and probiotic supplementation on gut microenvironment homeostasis: An open-label, randomized clinical trial EBioMedicine. 35 87-85
[9]  
Bedogni G(2012)Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity Nature. 482 179-80
[10]  
Wong VW(2017)Alcohol, microbiome, life style influence alcohol and non-alcoholic organ damage Exp Mol Pathol. 102 162-94